2. 2
Healthcare Innovation and Government Policy (HIGP) Department
“Improving Patient access and funding to healthcare innovation”
2
June 2016
By
Richard Murrugarra – Centurion
Head of Department

3. Healthcare targets presented to Mr Tanasescu – EU MEP
3

4. Healthcare Department 2016 targets
4
 Identify priorities in EU Healthcare agenda and support awareness for Ventricular Assist Devices and Heart Failure
 Identify lobbying mechanisms within the EU Healthcare environment
 Key priority  Funding: Allocation of funds to key EU regions to implement and develop advanced therapies (HF)
 Market analysis: services in partnership with Policy experts
 Patient advocacy: reinforced strategy
 Boast partnership with key bodies involved in EU Healthcare policy:
- DG Sante/DG Growth/DG Transport
- Medical Specialists associations i.e. UEMS
- Medical Societies from high prevalence diseases i.e. ESC, EACTS, ISHLT …
 Identify Key MEPs that could help us influence decision making on ongoing policies i.e. “Healthcare derogations”,
“committee of petitions”…
 Monthly roundtables on key priority healthcare topics at the European Economic and Social Committee (EESC):
 Assess strategy for industry partnership

5. 2016 Strategy
5
June 2016
Network alliances
Define
Strategy
Establish
Partnerships
Prepare New
Landscape for 2017
Elaborate
Tools/lobbying
strategy
Set agenda for monthly
EESC HC roundtables
Improved
Department
awareness
Initiate sociopolitical need
Industry partnership
2017:
Experts panel

6. Who are our main KOLs in advanced Heart Failure?
6

7. From process outline to strategic execution: VADs as Destination Therapy
7
Initiator
Recipient
Strategy
1
2
3
Lobbying Tools
Bringing the Influencers
on board
1) European Action Plan
2) Standard Care Document
Lobbyists
EAR

8. What is their level of Impact on EU legislation?
8
I N T E R E S T
I
m
p
a
ct
0
5
5
10
10

9. MEP Heart Group: existing initiatives
9
The Members of the European Parliament (MEP) Heart
Group is a forum which provides MEPs with an opportunity
to generate dialogue, outreach and activities at EU and
Member State level. It is made up of MEPs who have an
interest in promoting measures that will help reduce the
burden of cardiovascular diseases (CVD) in Europe and
raise CVD as a priority on the EU political agenda.
CVD is the main cause of death and disability in Europe. In
response to this, the European Heart Network (EHN) and
the European Society of Cardiology (ESC) are committed to
identifying specific areas of policies and public health
interventions which can contribute to preventing
avoidable deaths and disabilities from CVD.

10. Existing initiatives: EUROHEART
10
EuroHeart is a project co-funded by the European Commission Public Health Programme to strengthen
cross-sector cooperation, it was developed by the European Society of Cardiology along with the
European Heart Network and brings together 30 partners in 21 European countries.
Its general objective is to determine areas of policies and public health interventions which can
contribute to prevent avoidable deaths and disability across Europe.
 Map and analyse national plans, policies and measures impacting on cardiovascular health
promotion and cardiovascular disease prevention
 Mobilise broad support for cardiovascular health promotion and cardiovascular disease
prevention with a view to achieving stronger cross sector cooperation